Page last updated: 2024-10-26

fenbendazole and Hepatocellular Carcinoma

fenbendazole has been researched along with Hepatocellular Carcinoma in 2 studies

Fenbendazole: Antinematodal benzimidazole used in veterinary medicine.
fenbendazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted at positons 2 and 5 by (methoxycarbonyl)amino and phenylsulfanediyl groups, respectively. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections.

Research Excerpts

ExcerptRelevanceReference
"Fenbendazole (FBZ) is an anthelmintic drug known to be a potent CYP1A2 inducer."1.31Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole--a CYP1A2 inducer. ( Asamoto, M; Hirose, M; Inaguma, S; Ogiso, T; Shirai, T; Suzuki, S; Takahashi, S, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Park, D1
Suzuki, S1
Takahashi, S1
Asamoto, M1
Inaguma, S1
Ogiso, T1
Hirose, M1
Shirai, T1

Other Studies

2 other studies available for fenbendazole and Hepatocellular Carcinoma

ArticleYear
Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest.
    Biological & pharmaceutical bulletin, 2022, Volume: 45, Issue:2

    Topics: Antinematodal Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor

2022
Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole--a CYP1A2 inducer.
    Cancer letters, 2002, Nov-08, Volume: 185, Issue:1

    Topics: Animals; Antinematodal Agents; Arylamine N-Acetyltransferase; Blotting, Western; Carcinogens; Carcin

2002